These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 16413962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.
    Karussis D, Kassis I, Kurkalli BG, Slavin S.
    J Neurol Sci; 2008 Feb 15; 265(1-2):131-5. PubMed ID: 17610906
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders.
    Slavin S, Kurkalli BG, Karussis D.
    Clin Neurol Neurosurg; 2008 Nov 15; 110(9):943-6. PubMed ID: 18325660
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regeneration and repair in multiple sclerosis: the view of experimental pathology.
    Blakemore WF.
    J Neurol Sci; 2008 Feb 15; 265(1-2):1-4. PubMed ID: 17459413
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuroprotective features of mesenchymal stem cells.
    Uccelli A, Benvenuto F, Laroni A, Giunti D.
    Best Pract Res Clin Haematol; 2011 Mar 15; 24(1):59-64. PubMed ID: 21396593
    [Abstract] [Full Text] [Related]

  • 11. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS, Weiner HL.
    Nat Rev Drug Discov; 2008 Nov 15; 7(11):909-25. PubMed ID: 18974749
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B, Hartung HP.
    Ann Neurol; 2007 Oct 15; 62(4):314-26. PubMed ID: 17969020
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cellular remyelinating therapy in multiple sclerosis.
    Yang J, Rostami A, Zhang GX.
    J Neurol Sci; 2009 Jan 15; 276(1-2):1-5. PubMed ID: 18814888
    [Abstract] [Full Text] [Related]

  • 17. Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases.
    Colafrancesco V, Villoslada P.
    Arch Ital Biol; 2011 Jun 15; 149(2):183-92. PubMed ID: 21701990
    [Abstract] [Full Text] [Related]

  • 18. [Recent advances in pathogenesis and therapy of multiple sclerosis].
    Linker RA, Stadelmann C, Diem R, Bähr M, Brück W, Gold R.
    Fortschr Neurol Psychiatr; 2005 Dec 15; 73(12):715-27. PubMed ID: 16355314
    [Abstract] [Full Text] [Related]

  • 19. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H.
    PLoS Med; 2007 Apr 15; 4(4):e124. PubMed ID: 17425404
    [Abstract] [Full Text] [Related]

  • 20. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases.
    Kan I, Melamed E, Offen D.
    Handb Exp Pharmacol; 2007 Apr 15; (180):219-42. PubMed ID: 17554511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.